Publications by authors named "Jacob E Parriott"

Claim this Profile
E
Early-Stage IM Treatment with the Host-Derived Immunostimulant CPDI-02 Increases Curative Protection of Healthy Outbred Mice Against Subcutaneous Infection with Community-Acquired Methicillin-Resistant USA300.
Jason P Stewart, Caleb M Sandall, Jacob E Parriott, Stephen M Curran, Russell J McCulloh

Pharmaceutics· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Surface Modification of Biodegradable Microparticles with the Novel Host-Derived Immunostimulant CPDI-02 Significantly Increases Short-Term and Long-Term Mucosal and Systemic Antibodies against Encapsulated Protein Antigen in Young Naïve Mice after Respiratory Immunization.
Jacob E Parriott, Jason P Stewart, D David Smith, Stephen M Curran, Christopher D Bauer

Pharmaceutics· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis